Evidence map›Paper›PMID 37280478›Full record

ArticleEuropean radiology experimental2023

Deep learning for predicting future lesion emergence in high-risk breast MRI screening: a feasibility study.

Bianca Burger, Maria Bernathova, Philipp Seeböck, Christian F Singer, Thomas H Helbich, Georg Langs

Open access · goldAbstract read
In one paragraph

Article in European radiology experimental, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Bianca BurgerDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Computational Imaging Research (CIR), Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Maria BernathovaDepartment of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria.
Philipp SeeböckDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Computational Imaging Research (CIR), Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.ORCID 0000-0001-5512-5810
Christian F SingerDepartment of Obstetrics and Gynecology, Division of Special Gynecology, Medical University of Vienna, Vienna, Austria.
Thomas H HelbichDepartment of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria.
Georg LangsDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Computational Imaging Research (CIR), Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. georg.langs@meduniwien.ac.at.ORCID 0000-0002-5536-6873
Medical University of Vienna · ATComprehensive Cancer Center Vienna · ATMassachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInternational societies have issued guidelines for high-risk breast cancer (BC) screening, recommending contrast-enhanced magnetic resonance imaging (CE-MRI) of the breast as a supplemental diagnostic tool. In our study, we tested the applicability of deep learning-based anomaly detection to identify anomalous changes in negative breast CE-MRI screens associated with future lesion emergence.

methodsIn this prospective study, we trained a generative adversarial network on dynamic CE-MRI of 33 high-risk women who participated in a screening program but did not develop BC. We defined an anomaly score as the deviation of an observed CE-MRI scan from the model of normal breast tissue variability. We evaluated the anomaly score's association with future lesion emergence on the level of local image patches (104,531 normal patches, 455 patches of future lesion location) and entire CE-MRI exams (21 normal, 20 with future lesion). Associations were analyzed by receiver operating characteristic (ROC) curves on the patch level and logistic regression on the examination level.

resultsThe local anomaly score on image patches was a good predictor for future lesion emergence (area under the ROC curve 0.804). An exam-level summary score was significantly associated with the emergence of lesions at any location at a later time point (p = 0.045).

conclusionsBreast cancer lesions are associated with anomalous appearance changes in breast CE-MRI occurring before the lesion emerges in high-risk women. These early image signatures are detectable and may be a basis for adjusting individual BC risk and personalized screening. RELEVANCE STATEMENT: Anomalies in screening MRI preceding lesion emergence in women at high-risk of breast cancer may inform individualized screening and intervention strategies. KEY POINTS: • Breast lesions are associated with preceding anomalies in CE-MRI of high-risk women. • Deep learning-based anomaly detection can help to adjust risk assessment for future lesions. • An appearance anomaly score may be used for adjusting screening interval times.

Indexed as

Breast NeoplasmsDeep LearningContrast MediaFeasibility StudiesFemaleHumansMagnetic Resonance ImagingProspective StudiesContrast MediaBreast cancerDeep learningGenerative adversarial networkHigh-risk womenMagnetic resonance imaging

Identifiers

PMID37280478
PMCPMC10244308
OpenAlexW4379536510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.